DE69902657T2 - Hydroxyomeprazol-enthaltende zubereitungen und verwendungen - Google Patents

Hydroxyomeprazol-enthaltende zubereitungen und verwendungen

Info

Publication number
DE69902657T2
DE69902657T2 DE69902657T DE69902657T DE69902657T2 DE 69902657 T2 DE69902657 T2 DE 69902657T2 DE 69902657 T DE69902657 T DE 69902657T DE 69902657 T DE69902657 T DE 69902657T DE 69902657 T2 DE69902657 T2 DE 69902657T2
Authority
DE
Germany
Prior art keywords
hydroxyomeprazole
preparations
omeprazole
treatment
use containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69902657T
Other languages
English (en)
Other versions
DE69902657D1 (de
Inventor
E Yelle
A Handley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of DE69902657D1 publication Critical patent/DE69902657D1/de
Application granted granted Critical
Publication of DE69902657T2 publication Critical patent/DE69902657T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69902657T 1998-05-05 1999-05-05 Hydroxyomeprazol-enthaltende zubereitungen und verwendungen Expired - Fee Related DE69902657T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8425898P 1998-05-05 1998-05-05
PCT/US1999/009814 WO1999056746A1 (en) 1998-05-05 1999-05-05 Hydroxyomeprazole compositions and uses

Publications (2)

Publication Number Publication Date
DE69902657D1 DE69902657D1 (de) 2002-10-02
DE69902657T2 true DE69902657T2 (de) 2003-04-30

Family

ID=22183810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69902657T Expired - Fee Related DE69902657T2 (de) 1998-05-05 1999-05-05 Hydroxyomeprazol-enthaltende zubereitungen und verwendungen

Country Status (9)

Country Link
US (2) US6294586B1 (de)
EP (1) EP1082114B1 (de)
JP (1) JP2003517434A (de)
AT (1) ATE222764T1 (de)
AU (1) AU748872B2 (de)
CA (1) CA2330049A1 (de)
DE (1) DE69902657T2 (de)
ES (1) ES2182524T3 (de)
WO (1) WO1999056746A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420435B1 (en) * 1999-11-01 2002-07-16 Joe S. Wilkins, Jr. Method for treating gastrointestinal disorders
US6987123B2 (en) * 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7041706B2 (en) * 2002-04-19 2006-05-09 Wilkins Jr Joe S Method for treating crohn's disease
WO2004064719A2 (en) * 2003-01-24 2004-08-05 State Of Israel, Ministry Of Agriculture Synergistic compositions and methods for potentiating anti-oxidative activity
EP1667681A4 (de) * 2003-10-03 2009-09-30 Astron Res Pvt Ltd Neues transmukosales abgabesystem
ES2281292B1 (es) * 2006-03-08 2008-06-16 Quimica Sintetica S.A. Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden.

Also Published As

Publication number Publication date
WO1999056746A1 (en) 1999-11-11
EP1082114B1 (de) 2002-08-28
US6498171B2 (en) 2002-12-24
AU3971699A (en) 1999-11-23
DE69902657D1 (de) 2002-10-02
US6294586B1 (en) 2001-09-25
ES2182524T3 (es) 2003-03-01
CA2330049A1 (en) 1999-11-11
ATE222764T1 (de) 2002-09-15
JP2003517434A (ja) 2003-05-27
EP1082114A1 (de) 2001-03-14
AU748872B2 (en) 2002-06-13
US20020010196A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
CY1105349T1 (el) Θειαζολυλ-αναστολεις τυροκινασεων της οικογενειας tec
NO20061736L (no) Krystallform av epotilon B
NO20013770D0 (no) Metoder og blandinger for å öke antall hvite blodceller
DE69212430D1 (de) Copolymere aus Protein und Siloxan und diese enthaltende Zusammensetzungen
DE69425527T2 (de) Oxidation von Silizium-Nitrid in der Herstellung von Halbleitenden Anordnungen
HUP9702035A2 (hu) Leukocitaadhéziót gátló és VLA-4-antagonista vegyületek, valamint e vegyületeket tartalmazó gyógyászati készítmények
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
DE60011515D1 (de) Herstellung von Keramiksubstraten und ungesintertes Keramiksubstrat
WO2005099312A3 (en) Triarylamine compounds for use as charge transport materials
BR0111451A (pt) Inibidores de serina protease
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
NO20014314D0 (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
DE60224957D1 (de) Harzzusammensetzung zur Einkapselung von Halbleitern und diese enthaltende Halbleiteranordnungen
ATE349448T1 (de) Pyrazol-3,4-d-pyrimidinderivate und ihre verwendung bei der behandlung von h.pylori- infektionen
DK1083887T3 (da) Farmaceutisk præparat til behandling af ulcera
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
DE69902657T2 (de) Hydroxyomeprazol-enthaltende zubereitungen und verwendungen
NO984950D0 (no) Forbindelser med veksthormonfrigj°rende egenskaper
DE69710111D1 (de) Behandlung und Prophylaxe von Pankreatitis
DE69429101D1 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
DE50211985D1 (de) Verwendung von pyridin-2,4-dicarbons urediamiden und pyrimid in-4,6-dicarbons urediamiden zur selektiven inhibierung von kollagenasen
DK1075262T3 (da) Desmethylpantoprazolpræparater og -fremgangsmåder
ATE476435T1 (de) Siliziumzusammensetzungen
DE69231384T2 (de) Zusammensetzungen zur behandlung des chronischen erschöpfungs-syndroms

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee